(Q49056581)

18 February 2018

title

Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. (English)

1 reference

18 February 2018

0 references

1 reference

Zubieta JK

1

1 reference

18 February 2018

Taylor SF

2

1 reference

18 February 2018

Huguelet P

3

1 reference

18 February 2018

Koeppe RA

4

1 reference

18 February 2018

Kilbourn MR

5

1 reference

18 February 2018

Frey KA

6

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 January 2001

1 reference

18 February 2018

published in

Biological Psychiatry

1 reference

18 February 2018

volume

49

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

page(s)

110-116

1 reference

18 February 2018

Neonatal raphe lesions increase dopamine fibers in prefrontal cortex of adult rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Stereotaxic summation analysis of human cerebral benzodiazepine binding maps.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Firing frequency modulation of substantia nigra reticulata neurons by 5-hydroxytryptamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

A simple synthesis of [11C]dihydrotetrabenazine (DTBZ)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Expression and regulation of the bovine vesicular monoamine transporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Influence of spatially heterogeneous background activity on "hot object" quantitation in brain emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

MRI anatomy of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Three-dimensional mapping of norepinephrine and serotonin in human thalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Vesicular neurotransmitter transport and the presynaptic regulation of quantal size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Structural brain abnormalities in first-episode mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

CSF monoamine metabolites in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900981-1

10.1016/S0006-3223(00)00981-1

7 January 2021

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018